Sfoglia per AUTORE
GORI S
Collezione AO Ordine Mauriziano

  

Items : 13

Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis. in Current oncology reports / Curr Oncol Rep. 2023 Jul;25(7):743-751. doi: 10.1007/s11912-023-01411-7. Epub 2023 Apr 5.

2023
AO Ordine Mauriziano

Inno A; Tarantini L; Parrini I; Spallarossa P; Maurea N; Bisceglia I; Silvestris N; Russo A; Gori S;

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. in ESMO open / ESMO Open. 2022 Jun;7(3):100459. doi: 10.1016/j.esmoop.2022.100459. Epub 2022 May 19.

2022
AO Ordine Mauriziano

Sapino A; Jereczek-Fossa BA; Luchini C; Lapini A; Del Re M; Dessena M; Barberis M; Turchetti D; Di Maio M; De Giorgi U; Genuardi M; Gori S; Cortesi L; Capoluongo E; Tagliaferri P; Russo A; Incorvaia L; Cinieri S;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31

2022
AO Ordine Mauriziano

Brocco D; Porzio G; Piras M; Rijavec E; Simionato F; Natoli C; Santini D; Vincenzi B; Tonini G; Tiseo M; Marconcini R; Audisio M; Intagliata S; Lai E; Aprile G; Buti S; Ghidini M; Inno A; Macrini S; Di Marino P; Nicolardi L; Tuzi A; Occhipinti MA; Pergolesi F; Veltri E; Filetti M; Adamo V; Ficorella C; Citarella F; et alii...

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406]. in ESMO open / ESMO Open. 2022 Apr;7(2):100471. doi: 10.1016/j.esmoop.2022.100471. Epub 2022 Apr 1.

2022
AO Ordine Mauriziano

Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri MV; Emili R; Roca E; Migliore A; Galassi T; Rocchi MBL; Berardi R; Vallini I; Sforza V; Dellepiane C; Russo A; Bennati C; Morgillo F; Spinelli GP; Salerno F; Caglio A; D'Emilio V; Cona MS; Guida A; De Tursi M; Di Marino P; Toscano G; Zullo L; Piras M; Filetti M; et alii...

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. in ESMO open / ESMO Open. 2022 Apr;7(2):100406. doi: 10.1016/j.esmoop.2022.100406. Epub 2022 Feb 3.

2022
AO Ordine Mauriziano

Rocchi MLB; Berardi R; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri V; Emili R; Roca E; Migliore A; Galassi T; Russo A; Dellepiane C; Sforza V; Vallini I; Morgillo F; Bennati C; Spinelli G; Caglio A; Salerno F; Guida A; Di Marino P; D'Emilio V; Cona MS; De Tursi M; Zullo L; Toscano G; Piras M; Filetti M; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

Second medical opinion in oncological setting. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3.

2021
AO Ordine Mauriziano

Gori S; Marchetti P; Scagnoli S; Maruzzo M; La Verde N; Russo A; Nicolis F; Cinieri S; Comandone A; Bordonaro R; Beretta G; Lanzetta G; Perrone F; Galvano A; Zagonel V; Di Maio M; Gonzato O;

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.

2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.

2020
ASL Cuneo 2
AOU San Luigi di Orbassano
ASL Città di Torino
ASL VCO
AO Ordine Mauriziano
AOU Alessandria

Buti S; Tognetto M; Vaccaro V; Di Costanzo F; Maiello E; Labianca R; Pinto C; Garzoli E; Pilotto S; Castro A; Carrozza F; Gori S; Verusio C; Atzori F; Dicorato AM; Giordano P; Corbo C; Gernone A; Prati V; Carnio S; Tassinari D; Cavanna L; Meriggi F; Longo L; Sartori D; Iannopollo M; Pezzuolo D; Bracarda S; Bonetti A; et alii...

Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) in Journal of Endocrinological Investigation

2018
AO Ordine Mauriziano

Faustini-Fustini M; Fiaccadori E; Gesualdo L; Corona G; Della Casa S; De Nicola L; Capasso G; Caprio M; Ceccato F; Barone C; Benso A; Berardi R; Arnaldi G; Arosio M; Isidori AM; Sbardella E; Peri A; Regolisti G; Scaroni C; Trepiccione F; Lenzi A; Parenti G; Pinto C; Pivonello R; Razzore P; Gori S; Lania A; Mantovani G; Menè P; et alii...

Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement. in Tumori / Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582.

2016
AO Ordine Mauriziano
AO Cuneo

Bordonaro R; Labianca R; Micallo G; Fioretto L; Zagonel V; Merlano M; Passalacqua R; Crispino S; Di Costanzo F; De Cicco M; Mancuso A; Omodeo Salè E; Di Maio M; Perrone F; Nicolis F; Iacono C; Spinsanti S; Comandone A; Marchetti P; Aprile G; Caminiti C; Pinto C; Gori S;